Evidence map›Paper›PMID 26594244›Full record

ArticleGut pathogens2015

Description of Campylobacter jejuni Bf, an atypical aero-tolerant strain.

Ramila Cristiane Rodrigues, Anne-Lise Pocheron, Mathieu Hernould, Nabila Haddad, Odile Tresse, Jean-Michel Cappelier

Abstract read
In one paragraph

Article in Gut pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Comparative Genomic Analysis of Livestock-DerivedJournal of microbiology and biotechnology · 2025
    Article
  4. Aerotolerancy ofPathogens (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Survival ofPathogens (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Waterborne Isolates ofFrontiers in microbiology · 2021
    Article
  11. Investigating Major RecurringFrontiers in cellular and infection microbiology · 2020
    Article
  12. RevisitingFrontiers in cellular and infection microbiology · 2020
    Review
  13. Hyper-AerotolerantMicroorganisms · 2019
    Article
  14. Article
  15. Current Status ofFood safety (Tokyo, Japan) · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Frontiers in microbiology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramila Cristiane RodriguesONIRIS National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet - La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France ; Institut National de la Recherche Agronomique (INRA), Rue de la Geraudière, 44000 Nantes, France.
Anne-Lise PocheronONIRIS National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet - La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France ; Institut National de la Recherche Agronomique (INRA), Rue de la Geraudière, 44000 Nantes, France.
Mathieu HernouldONIRIS National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet - La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France ; Institut National de la Recherche Agronomique (INRA), Rue de la Geraudière, 44000 Nantes, France.
Nabila HaddadONIRIS National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet - La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France ; Institut National de la Recherche Agronomique (INRA), Rue de la Geraudière, 44000 Nantes, France.
Odile TresseONIRIS National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet - La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France ; Institut National de la Recherche Agronomique (INRA), Rue de la Geraudière, 44000 Nantes, France.
Jean-Michel CappelierONIRIS National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet - La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France ; Institut National de la Recherche Agronomique (INRA), Rue de la Geraudière, 44000 Nantes, France.ORCID 0000-0003-2947-8609

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCampylobacter jejuni is a leading cause of bacterial enteritis worldwide. This microaerophilic bacterium can survive in aerobic environments, suggesting it has protective mechanisms against oxidative stress. The clinical C. jejuni Bf strain is characterized by an increased resistance to oxygen. This study aimed to characterize the behavior of the clinical C. jejuni Bf strain under an aerobic atmosphere and in response to ROS-promoter agents.

methodsGrowth was studied in both aerobic and microaerobic conditions using classic cultivable methods. Electronic microscopy and mreB gene expression were used to evaluate the morphology of this strain under aerobic conditions. The survival under oxidative stress was tested in the presence of different concentrations of hydrogen peroxide (H2O2) and paraquat (PQ).

resultsThe results showed that C. jejuni Bf strain can grow aerobically, unlike other strains of C. jejuni tested. Cells of C. jejuni Bf exposed to oxidative stress presented changes in morphology and the gene mreB, responsible for maintaining the bacillary cell morphology, was down-expressed. In aerobically acclimated conditions, C. jejuni Bf exhibited a higher survival rate of 52 % in the presence of H2O2 (1 mM) compared to the reference strain NCTC 11168. Concentrations above 1 mM PQ were lethal for the reference strain but not for C. jejuni Bf.

conclusionsTaken together, these data highlight the resistance to oxidative stress conditions of C. jejuni Bf, indicating that this microorganism seems more adapted to survival in hostile environmental conditions.

Indexed as

Campylobacter jejuniCell shapeHydrogen peroxideOxygen toleranceParaquat

Identifiers

PMID26594244
PMCPMC4653858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.